$250 Million is the total value of Altium Capital Management LP's 127 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | $5,285,000 | -16.1% | 268,000 | 0.0% | 2.12% | +0.3% | |
| CBAY | CYMABAY THERAPEUTICS INC | $5,163,000 | -5.1% | 1,750,000 | 0.0% | 2.07% | +13.4% | |
| MBTC | NOCTURNE ACQUISITION CORPordinary shares | $5,095,000 | +1.1% | 500,000 | 0.0% | 2.04% | +20.9% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $3,960,000 | +0.6% | 400,000 | 0.0% | 1.58% | +20.3% | |
| XTNT | XTANT MED HLDGS INC | $3,245,000 | -23.6% | 6,246,291 | 0.0% | 1.30% | -8.7% | |
| LIVN | LIVANOVA PLC | $3,124,000 | -23.7% | 50,000 | 0.0% | 1.25% | -8.7% | |
| OCUL | OCULAR THERAPEUTIX INC | $2,794,000 | -18.8% | 695,000 | 0.0% | 1.12% | -2.9% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $2,772,000 | -24.1% | 440,000 | 0.0% | 1.11% | -9.2% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $2,518,000 | +0.6% | 254,000 | 0.0% | 1.01% | +20.4% | |
| KRMD | REPRO MED SYS INC | $2,519,000 | -11.5% | 995,500 | 0.0% | 1.01% | +5.8% | |
| ISEE | IVERIC BIO INC | $2,270,000 | -42.8% | 236,000 | 0.0% | 0.91% | -31.7% | |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $2,225,000 | -0.1% | 225,000 | 0.0% | 0.89% | +19.3% | |
| GIGINTERNATIONAL1 INC | $2,010,000 | +0.5% | 200,000 | 0.0% | 0.80% | +20.2% | ||
| TG VENTURE ACQUISITION CORPunit 08/15/2028 | $2,000,000 | -0.2% | 200,000 | 0.0% | 0.80% | +19.2% | ||
| CHAVANT CAPITAL ACQUISITN COordinary shares | $1,996,000 | +0.7% | 200,000 | 0.0% | 0.80% | +20.5% | ||
| LAKESHORE ACQUISITION I CORPordinary shares | $1,997,000 | +0.8% | 200,000 | 0.0% | 0.80% | +20.5% | ||
| JYAC | JIYA ACQUISITION CORP | $1,976,000 | +0.5% | 200,000 | 0.0% | 0.79% | +20.2% | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1,767,000 | -35.2% | 224,541 | 0.0% | 0.71% | -22.6% | |
| GOEDWS | 1847 GOEDEKER INC*w exp 06/02/202 | $1,588,000 | -58.0% | 6,103,824 | 0.0% | 0.64% | -49.8% | |
| DIGITAL HEALTH ACQUISITION Cunit 11/02/2026 | $1,515,000 | 0.0% | 150,000 | 0.0% | 0.61% | +19.5% | ||
| AULT DISRUPTIVE TECHS CORP | $1,503,000 | +0.5% | 150,000 | 0.0% | 0.60% | +20.0% | ||
| MORF | MORPHIC HLDG INC | $1,302,000 | -46.0% | 60,000 | 0.0% | 0.52% | -35.4% | |
| TWND | TAILWIND ACQUISITION CORP | $1,278,000 | +0.6% | 128,414 | 0.0% | 0.51% | +20.2% | |
| RELATIVITY ACQUISITION CORPunit 02/10/2027 | $1,025,000 | +1.8% | 100,000 | 0.0% | 0.41% | +21.7% | ||
| MURPHY CANYON ACQUISITION COunit 01/25/2027 | $1,012,000 | +0.2% | 100,000 | 0.0% | 0.40% | +19.8% | ||
| INDUSTRIAL HUMAN CAPITAL INC | $1,003,000 | +0.1% | 100,000 | 0.0% | 0.40% | +19.7% | ||
| WESTERN ACQSTN VENTURES CORPunit 09/01/2026 | $1,000,000 | 0.0% | 100,000 | 0.0% | 0.40% | +19.4% | ||
| BLSA | BCLS ACQUISITION CORP | $990,000 | +0.3% | 100,000 | 0.0% | 0.40% | +20.0% | |
| OMEG | OMEGA ALPHA SPACcl a | $985,000 | +0.3% | 100,000 | 0.0% | 0.39% | +19.8% | |
| OPY ACQUISITION CORP I | $984,000 | +0.4% | 100,000 | 0.0% | 0.39% | +20.1% | ||
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $981,000 | +0.1% | 100,000 | 0.0% | 0.39% | +19.8% | |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $965,000 | -5.6% | 227,000 | 0.0% | 0.39% | +12.9% | |
| COLISEUM ACQUISITION CORP | $827,000 | +0.2% | 85,000 | 0.0% | 0.33% | +19.9% | ||
| RENOVACOR INC | $788,000 | -52.2% | 388,845 | 0.0% | 0.32% | -42.9% | ||
| GRIL | MUSCLE MAKER INC | $692,000 | -27.0% | 1,796,961 | 0.0% | 0.28% | -12.6% | |
| DOUBLEDOWN INTERACTIVE CO LTads | $588,000 | -18.6% | 60,876 | 0.0% | 0.24% | -2.9% | ||
| GSR II METEORA ACQUISITN CORunit 02/24/2027 | $499,000 | -1.4% | 50,000 | 0.0% | 0.20% | +18.3% | ||
| CLBR | COLOMBIER ACQUISITION CORPcl a | $488,000 | +0.8% | 50,000 | 0.0% | 0.20% | +20.4% | |
| SURGEPAYS INC*w exp 10/22/202 | $300,000 | +34.5% | 250,000 | 0.0% | 0.12% | +60.0% | ||
| ZEVWS | LIGHTNING EMOTORS INC*w exp 05/18/202 | $255,000 | -4.9% | 652,173 | 0.0% | 0.10% | +13.3% | |
| HARBOR CUSTOM DEVELOPMENT IN*w exp 10/04/202 | $244,000 | +1.7% | 650,000 | 0.0% | 0.10% | +22.5% | ||
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $223,000 | -51.6% | 941,176 | 0.0% | 0.09% | -42.2% | ||
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $199,000 | +16.4% | 97,467 | 0.0% | 0.08% | +40.4% | |
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $116,000 | -32.2% | 600,000 | 0.0% | 0.05% | -19.3% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $100,000 | +1.0% | 10,000 | 0.0% | 0.04% | +21.2% | |
| CINGULATE INC*w exp 12/10/202 | $85,000 | -21.3% | 270,000 | 0.0% | 0.03% | -5.6% | ||
| PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $76,000 | -50.0% | 367,500 | 0.0% | 0.03% | -41.2% | ||
| DIRECT DIGITAL HOLDINGS INC*w exp 02/15/202 | $70,000 | -46.6% | 180,000 | 0.0% | 0.03% | -36.4% | ||
| NEXGEL INC*w exp 12/01/202 | $63,000 | -28.4% | 225,000 | 0.0% | 0.02% | -13.8% | ||
| CEA INDUSTRIES INC*w exp 02/11/202 | $60,000 | -64.9% | 250,000 | 0.0% | 0.02% | -57.9% | ||
| RENOVACOR INC*w exp 99/99/999 | $51,000 | -79.5% | 731,561 | 0.0% | 0.02% | -75.9% | ||
| LAKESHORE ACQUISITION I CORP*w exp 07/15/202 | $27,000 | -49.1% | 150,000 | 0.0% | 0.01% | -38.9% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 09/25/202 | $24,000 | -68.4% | 200,000 | 0.0% | 0.01% | -60.0% | |
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $20,000 | -81.0% | 500,000 | 0.0% | 0.01% | -77.1% | |
| SURROZEN INC*w exp 08/01/203 | $16,000 | -23.8% | 82,233 | 0.0% | 0.01% | -14.3% | ||
| OPY ACQUISITION CORP I*w exp 09/22/202 | $9,000 | -55.0% | 50,000 | 0.0% | 0.00% | -42.9% | ||
| CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $11,000 | -63.3% | 150,000 | 0.0% | 0.00% | -60.0% | ||
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $9,000 | -64.0% | 133,333 | 0.0% | 0.00% | -50.0% | |
| AULT DISRUPTIVE TECHS CORP*w exp 99/99/999 | $7,000 | -63.2% | 112,500 | 0.0% | 0.00% | -50.0% | ||
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $8,000 | -66.7% | 84,666 | 0.0% | 0.00% | -62.5% | |
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $6,000 | -77.8% | 75,000 | 0.0% | 0.00% | -77.8% | |
| GIGINTERNATIONAL1 INC*w exp 04/19/202 | $4,000 | -77.8% | 50,000 | 0.0% | 0.00% | -66.7% | ||
| INDUSTRIAL HUMAN CAPITAL INC*w exp 11/27/202 | $4,000 | -77.8% | 100,000 | 0.0% | 0.00% | -66.7% | ||
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $3,000 | -70.0% | 28,333 | 0.0% | 0.00% | -66.7% | ||
| CLBRWS | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $2,000 | -60.0% | 16,666 | 0.0% | 0.00% | -50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.